Skip to main content
Top
Published in: Systematic Reviews 1/2017

Open Access 01-12-2017 | Protocol

Risk factors for addiction among patients receiving prescribed opioids: a systematic review protocol

Authors: Amber Cragg, Jeffrey P. Hau, Stephanie A. Woo, Christine Liu, Mary M. Doyle-Waters, Corinne M. Hohl

Published in: Systematic Reviews | Issue 1/2017

Login to get access

Abstract

Background

Opioid addiction prevention has become an urgent public health priority, with several countries declaring a state of emergency due to rising death tolls from opioid abuse. Reducing the risk of developing addiction among opioid-naïve patients exposed to prescribed opioids during the process of medical care may be an important primary prevention strategy. Our objective is to synthesize the available evidence about factors associated with the development of addiction among patients first exposed to prescribed opioids, with a focus on opioid-naïve patients.

Methods

We will perform a systematic search of MEDLINE, Embase, Cochrane Central Register of Controlled Trials, and other databases in collaboration with a health information specialist using a comprehensive search strategy. We will also supplement our search with a scan of the grey literature to identify relevant ongoing and unpublished studies. We will include studies reporting on risk factors for opioid addiction in patients prescribed opioid analgesic therapy through a prescription from a licensed medical professional, with a focus on opioid-naïve patients. We will exclude studies focusing on patients who are first exposed to illicit opioids, those who use prescription opioids for cancer pain, and/or who are palliative. Two reviewers will independently review titles, abstracts, and full texts for inclusion and exclusion criteria. They will then extract data from included full texts using standardized piloted data extraction forms and assess study quality through risk of bias assessment. We will synthesize the effect sizes of risk factors derived from clinically homogenous studies with similar designs and the remaining ones qualitatively.

Discussion

Understanding risk factors for opioid addiction among patients who require analgesia has the potential to inform clinical care and opioid prescribing guidelines aiming to reduce opioid addiction. We will also use this information as a starting point for developing interventions for primary prevention.
Appendix
Available only for authorised users
Literature
1.
go back to reference Paulozzi LJ. Prescription drug overdoses: a review. J Saf Res. 2012;43(4):283–9.CrossRef Paulozzi LJ. Prescription drug overdoses: a review. J Saf Res. 2012;43(4):283–9.CrossRef
2.
go back to reference Wachholtz A, Gonzalez G, Boyer E, et al. Intersection of chronic pain treatment and opioid analgesic misuse: causes, treatments, and policy strategies. Subst Abuse Rehabil. 2011;2:145–62.CrossRefPubMedPubMedCentral Wachholtz A, Gonzalez G, Boyer E, et al. Intersection of chronic pain treatment and opioid analgesic misuse: causes, treatments, and policy strategies. Subst Abuse Rehabil. 2011;2:145–62.CrossRefPubMedPubMedCentral
3.
go back to reference World Health Organization. International Statistical Classification of Diseases and Related Health Problems 10th Revision (ICD-10). Geneva: World Health Organization; 2016. World Health Organization. International Statistical Classification of Diseases and Related Health Problems 10th Revision (ICD-10). Geneva: World Health Organization; 2016.
4.
go back to reference Jones CM. Heroin use and heroin use risk behaviors among nonmedical users of prescription opioid pain relievers—United States, 2002-2004 and 2008-2010. Drug Alcohol Depend. 2013;132(1–2):95–100.CrossRefPubMed Jones CM. Heroin use and heroin use risk behaviors among nonmedical users of prescription opioid pain relievers—United States, 2002-2004 and 2008-2010. Drug Alcohol Depend. 2013;132(1–2):95–100.CrossRefPubMed
6.
go back to reference Canadian Centre on Substance Abuse. Canadian drug summary: prescription opioids, 2015. Canadian Centre on Substance Abuse. Canadian drug summary: prescription opioids, 2015.
7.
go back to reference Degenhardt L, Hall W. Extent of illicit drug use and dependence, and their contribution to the global burden of disease. Lancet. 2012;379:55–70.CrossRefPubMed Degenhardt L, Hall W. Extent of illicit drug use and dependence, and their contribution to the global burden of disease. Lancet. 2012;379:55–70.CrossRefPubMed
8.
go back to reference Lynskey MT, Fergusson DM. Childhood conduct problems, attention deficit behaviors, and adolescent alcohol, tobacco, and illicit drug use. J Abnorm Child Psychol. 1995;23(3):281–302.CrossRefPubMed Lynskey MT, Fergusson DM. Childhood conduct problems, attention deficit behaviors, and adolescent alcohol, tobacco, and illicit drug use. J Abnorm Child Psychol. 1995;23(3):281–302.CrossRefPubMed
9.
go back to reference MacCoun R, Kilmer B, Reuter P. Research on drugs-crime linkages: the next generation. In: Ashcroft J, Daniels DJ, Hart SV, editors. Toward a drugs and crime research agenda for the 21st century. Washington, DC: U.S. Department of Justice; 2003. MacCoun R, Kilmer B, Reuter P. Research on drugs-crime linkages: the next generation. In: Ashcroft J, Daniels DJ, Hart SV, editors. Toward a drugs and crime research agenda for the 21st century. Washington, DC: U.S. Department of Justice; 2003.
10.
11.
go back to reference Coughlin PA, Mavor AID. Arterial consequences of recreational drug use. Eur J Vasc Endovasc Surg. 2006;32:389–96.CrossRefPubMed Coughlin PA, Mavor AID. Arterial consequences of recreational drug use. Eur J Vasc Endovasc Surg. 2006;32:389–96.CrossRefPubMed
12.
go back to reference Schneider GS. Virginia declares opioid emergency, makes antidote available to all. 2016. Schneider GS. Virginia declares opioid emergency, makes antidote available to all. 2016.
13.
go back to reference Dhillon S, Howlett K. B.C. declares public health emergency as overdoses surge again. 2016. Dhillon S, Howlett K. B.C. declares public health emergency as overdoses surge again. 2016.
14.
go back to reference Manchikanti L. Prescription drug abuse: what is being done to address this new drug epidemic? Testimony before the Subcommittee on Criminal Justice, Drug Policy and Human Resources. Pain Physician. 2006;9(4):287–321.PubMed Manchikanti L. Prescription drug abuse: what is being done to address this new drug epidemic? Testimony before the Subcommittee on Criminal Justice, Drug Policy and Human Resources. Pain Physician. 2006;9(4):287–321.PubMed
15.
go back to reference National Opioid Use Guideline Group. Canadian Guideline for Safe and Effective Use of Opioids for Chronic Non-Cancer Pain: recommendations for practice.2010. National Opioid Use Guideline Group. Canadian Guideline for Safe and Effective Use of Opioids for Chronic Non-Cancer Pain: recommendations for practice.2010.
16.
go back to reference Fishbain DA, Cole B, Lewis J, et al. What percentage of chronic nonmalignant pain patients exposed to chronic opioid analgesic therapy develop abuse/addiction and/or aberrant drug-related behaviors? Pain Med. 2008;9(4):444–59.CrossRefPubMed Fishbain DA, Cole B, Lewis J, et al. What percentage of chronic nonmalignant pain patients exposed to chronic opioid analgesic therapy develop abuse/addiction and/or aberrant drug-related behaviors? Pain Med. 2008;9(4):444–59.CrossRefPubMed
17.
go back to reference Turk DC, Swanson KS, Gatchel RJ. Predicting opioid misuse by chronic pain patients: a systematic review and literature synthesis. Clin J Pain. 2008;24(6):497–508.CrossRefPubMed Turk DC, Swanson KS, Gatchel RJ. Predicting opioid misuse by chronic pain patients: a systematic review and literature synthesis. Clin J Pain. 2008;24(6):497–508.CrossRefPubMed
18.
go back to reference Moher D, Shamseer L, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Systematic Reviews. 2015;4(1):1.CrossRefPubMedPubMedCentral Moher D, Shamseer L, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Systematic Reviews. 2015;4(1):1.CrossRefPubMedPubMedCentral
20.
go back to reference Campbell G, Bruno R, Lintzeris N, et al. Defining problematic pharmaceutical opioid use among people prescribed opioids for chronic noncancer pain: do different measures identify the same patients? Pain. 2016;157(7):1489–98.CrossRefPubMed Campbell G, Bruno R, Lintzeris N, et al. Defining problematic pharmaceutical opioid use among people prescribed opioids for chronic noncancer pain: do different measures identify the same patients? Pain. 2016;157(7):1489–98.CrossRefPubMed
21.
go back to reference World Health Organization. Guidelines for the psychosocially assisted pharmacological treatment of opioid dependence. Geneva: Department of Mental Health and Substance Abuse; 2009. World Health Organization. Guidelines for the psychosocially assisted pharmacological treatment of opioid dependence. Geneva: Department of Mental Health and Substance Abuse; 2009.
22.
go back to reference Shalmi CL. Opioids for nonmalignant pain: issues and controversy. In: Warfield CA, Bajwa ZH, eds. Principles and practice of pain medicine Columbus, OH: McGraw-Hill Companies Inc. 2004:607. Shalmi CL. Opioids for nonmalignant pain: issues and controversy. In: Warfield CA, Bajwa ZH, eds. Principles and practice of pain medicine Columbus, OH: McGraw-Hill Companies Inc. 2004:607.
24.
go back to reference Stroup D, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283(15):2008–12.CrossRefPubMed Stroup D, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283(15):2008–12.CrossRefPubMed
25.
go back to reference Bruehl S, Apkarian AV, Ballantyne JC, et al. Personalized medicine and opioid analgesic prescribing for chronic pain: opportunities and challenges. J Pain. 2013;14(2):103–13.CrossRefPubMedPubMedCentral Bruehl S, Apkarian AV, Ballantyne JC, et al. Personalized medicine and opioid analgesic prescribing for chronic pain: opportunities and challenges. J Pain. 2013;14(2):103–13.CrossRefPubMedPubMedCentral
27.
go back to reference Swarm R, Pickar A, Anghelescu DL, et al. Adult cancer pain. J Natl Compr Cancer Netw. 2013;8(9):1046–86.CrossRef Swarm R, Pickar A, Anghelescu DL, et al. Adult cancer pain. J Natl Compr Cancer Netw. 2013;8(9):1046–86.CrossRef
28.
go back to reference Ballantyne JC. Opioid analgesia: perspectives on right use and utility. Pain Physician. 2007;10(3):479–91.PubMed Ballantyne JC. Opioid analgesia: perspectives on right use and utility. Pain Physician. 2007;10(3):479–91.PubMed
Metadata
Title
Risk factors for addiction among patients receiving prescribed opioids: a systematic review protocol
Authors
Amber Cragg
Jeffrey P. Hau
Stephanie A. Woo
Christine Liu
Mary M. Doyle-Waters
Corinne M. Hohl
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Systematic Reviews / Issue 1/2017
Electronic ISSN: 2046-4053
DOI
https://doi.org/10.1186/s13643-017-0642-0

Other articles of this Issue 1/2017

Systematic Reviews 1/2017 Go to the issue